Chiesi USA (United States)

Chiesi USA is the American subsidiary of Chiesi Farmaceutici, an international pharmaceutical group specializing in respiratory medicine, neonatology, and rare diseases. The company develops treatments for asthma, COPD, cystic fibrosis, neonatal respiratory distress syndrome, and rare metabolic disorders. Key products include surfactant therapy for premature infants and specialty respiratory medications.